Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Medical Care Research and Review : MCRR|May 3, 2006
Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug AdministrationKathryn A Phillips, Stephanie L Van BebberPharmacogenomics|December 9, 2004
A systematic review of cost-effectiveness analyses of pharmacogenomic interventionsKathryn A Phillips, Stephanie L Van BebberNature Reviews. Drug Discovery|May 26, 2005
Measuring the value of pharmacogenomicsKathryn A Phillips, Stephanie L Van BebberMilitary Medicine|April 1, 2015
Interest in a digital health tool in veterans with epilepsy: results of a phone surveyJohn D Hixson, Stephanie L Van Bebber, Kate M BertkoJournal of Oncology Practice|January 4, 2011
Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assayJulia R Trosman, Stephanie L Van Bebber, Kathryn A PhillipsPersonalized Medicine|May 24, 2018
Initial development of an evidence base for personalized medicine's translation to clinical practice and health policyKathryn A Phillips, Stephanie L Van Bebber, Amalia M IssaThe American Journal of Managed Care|June 30, 2011
Health technology assessment and private payers's coverage of personalized medicineJulia R Trosman, Stephanie L Van Bebber, Kathryn A PhillipsJournal of Oncology Practice|September 3, 2011
Health technology assessment and private payers' coverage of personalized medicineJulia R Trosman, Stephanie L Van Bebber, Kathryn A PhillipsPersonalized Medicine|May 24, 2018
Novel personalized medicine technology: UGT1A1 testing for irinotecan as a case studyStephanie L Van Bebber, Hugh L Keegan, Kathryn A Phillips, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 15, 2011
Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancerRobin K Kelley, Stephanie L Van Bebber, Kathryn A Phillips, et al.Pageof 2